Trademarkia Logo

United Kingdom

£
Registered

on 1 Mar 2024

Last Applicant/ Owned by

Solve Therapeutics, Inc.

1025 Alameda de las Pulgas, Suite 122

Belmont, California, 94002

Serial Number

UK00004020791 filed on 1st Mar 2024

Registration Number

UK00004020791 registered on
24th May 2024

Correspondent Information

Cooley (UK) LLP

22 Bishopsgate

London,

EC2N 4BQ

CLOAKLINK

chemical products for medicinal and pharmaceutical use, namely, monoclonal-antibody-drug-conjugate preparations for the treatment of cancer or other i Read More

Classification Information


Class [5]
Pharmaceutical Products


Chemical products for medicinal and pharmaceutical use, namely, monoclonal-antibody-drug-conjugate preparations for the treatment of cancer or other indicated human disease; pharmaceutical products for the treatment of cancer, autoimmune diseases, and viral infections; preparations for the medical treatment of cancer consisting of a monoclonal antibody (mAb) or antibody fragment connected to an anticancer payload or toxin or immune-stimulant via a chemical linker; chemical reagents for medical use.

Mark Details


Serial Number

UK00004020791

Mark Type

Word

Kind of mark

Individual